Zenosense, Inc. — MIDS Hybrid Strip Detection Testing to Commence

Press release Jul 05, 2017 OTC Disclosure & News Service Zenosense, Inc. — MIDS Hybrid Strip Detection Testing to Commence VALENCIA, SPAIN–(Marketwired – Jul 5, 2017) – Zenosense, Inc. (OTC PINK: ZENO) (“Zenosense”, the “Company”), a healthcare technology company primarily focused on the development and commercialization of MIDS Cardiac™, a Point of Care (“POC”) handheld…